Dutch stem cell biotech Neuroplast secures € 10 million (US$ 11.5 million) in Series B funding to further advance its transformative stem cell therapy for Traumatic Spinal Cord Injury
- Wednesday, November 17, 2021, 7:28
- PR Newswire
- Add a comment
GELEEN, Netherlands, Nov. 17, 2021 /PRNewswire/ — Dutch clinical phase biotech Neuroplast raised a total of € 10 million (US$ 11.5 million) in funding from investors Lumana Invest, Brightlands Venture Partners, LIOF, and from the Innovation Credit from the Netherlands Enterprise Agency,…
About the Author
admin has written 21721 stories on this site.